News

Dr. Reddy’s and OneSource agree not to sell Novo Nordisk’s anti-obesity drug in India amid patent infringement lawsuit.
It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...